Louisiana Health Chief Joins CDC as Deputy Director
What happened
Louisiana's surgeon general, Dr. Ralph Abraham, has been appointed as the deputy director of the Centers for Disease Control and Prevention (CDC). Dr. Abraham is known for his critical stance on COVID-19 vaccines and has previously praised Robert F. Kennedy Jr.'s role as health secretary.
Key facts
- Dr. Ralph Abraham is currently the surgeon general of Louisiana.
- He has expressed criticism of COVID-19 vaccines, labeling them as "dangerous."
- Dr. Abraham has praised Robert F. Kennedy Jr.'s tenure as health secretary.
- He will become the second-highest ranking official at the CDC.
- The appointment was reported by NPR on November 26, 2025.
Background & context
The Centers for Disease Control and Prevention (CDC) is a national public health institute in the United States, tasked with protecting public health and safety through the control and prevention of disease, injury, and disability. The CDC has been a central figure in the U.S. response to the COVID-19 pandemic, advocating for widespread vaccination as a critical measure to curb the virus's spread. Vaccines have been a cornerstone of public health strategy, significantly reducing the incidence of infectious diseases worldwide. The appointment of Dr. Ralph Abraham, who has publicly criticized COVID-19 vaccines, introduces a new dynamic to the leadership of an agency that has been a staunch advocate for vaccination.
Why it matters (for US readers)
Dr. Abraham's appointment to a high-ranking position within the CDC is significant due to his previous public statements on COVID-19 vaccines. His views may influence the agency's approach to vaccine policy and public health messaging. This development is particularly relevant as the U.S. continues to navigate the ongoing challenges of the pandemic and public health strategy. The CDC's policies and recommendations are influential, affecting not only federal and state health guidelines but also the public's perception and acceptance of health measures. As the nation continues to deal with the ramifications of the pandemic, including vaccine hesitancy and misinformation, leadership changes at the CDC could have far-reaching implications.
Stakeholders & viewpoints
- Public health officials: May be concerned about the implications of Dr. Abraham's views on vaccine policy. The CDC's stance on vaccines has been a critical component of its public health strategy, and any shift could impact ongoing efforts to manage the pandemic.
- Vaccine critics: Could view his appointment as a positive step towards more diverse perspectives within the CDC. This group may feel that Dr. Abraham's presence could lead to a more balanced discussion on vaccine policies and public health measures.
- General public: Likely to have varied reactions, depending on individual views on vaccines and public health measures. Public trust in health institutions is crucial, and changes in leadership can influence public confidence and compliance with health recommendations.
Timeline & what to watch next
- Dr. Abraham's transition to the CDC is expected to take place in the near future. The exact timeline of his appointment and the subsequent integration into the CDC's leadership structure will be closely watched.
- Observers will be watching for any shifts in CDC policy or public health messaging following his appointment. Changes in communication strategies or policy recommendations could signal a shift in the agency's approach to managing public health issues.
- Reactions from public health communities and stakeholders will be important to monitor. The response from both domestic and international health organizations could provide insight into the broader implications of this leadership change.
Sources
Up Next
